CYC Share Price Performance
AU$0.98
-0.45 (-31.47%)
Price AU$0.98
Share PriceAU$0.98
CYC Community Narratives
There are no narratives available yet.
Recent CYC News & Updates
No updates
Cyclopharm Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.12
- Gross Margin
- 65.04%
- Net Profit Margin
- -47.87%
- Debt/Equity Ratio
- 0%
Cyclopharm Limited Competitors
About CYC
- Founded
- 1986
- Employees
- 95
- CEO
- WebsiteView website
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Australian Market Performance
- 7 Days: -0.2%
- 3 Months: 6.6%
- 1 Year: 8.6%
- Year to Date: 5.1%
In the last week, the market has been flat, with a notable exception in the Materials sector dropping 4.2%. More promisingly, the market is up 8.6% over the past year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading